As of Aug 17
| -0.08 / -3.10%|
The 2 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 6.60, with a high estimate of 7.50 and a low estimate of 5.70. The median estimate represents a +164.00% increase from the last price of 2.50.
The current consensus among 2 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.